Cargando…

Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-Infected Patients Treated with Highly Active Antiretroviral Therapy (HAART)

Lipodystrophy is a common complication in HIV-infected patients taking highly active antiretroviral therapy. Its early diagnosis is crucial for timely modification of antiretroviral therapy. We hypothesize that mitochondrial DNA in plasma may be a potential marker of LD in HIV-infected individuals....

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Z., Cai, W., Hu, F., Lan, Y., Li, L., Chung, C., Caughey, B., Zhang, K., Tang, X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403959/ https://www.ncbi.nlm.nih.gov/pubmed/26592244 http://dx.doi.org/10.2174/1566524016666151123114401

Ejemplares similares

HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

Lipodystrophy among patients with HIV infection on antiretroviral therapy: a systematic review protocol
por: Lana, Lorena Gomes Cunha, et al.
Publicado: (2014)

Study on plasma metabolomics for HIV/AIDS patients treated by HAART based on LC/MS-MS
por: Lao, Donghui, et al.
Publicado: (2022)

Additional attention to combination antiretroviral therapy-related lipodystrophy
por: Kobayashi, Norihiko, et al.
Publicado: (2017)

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
por: Low, Yee Shan, et al.
Publicado: (2018)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study
por: Domingo, Pere, et al.
Publicado: (2014)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
por: Bisicchia, F, et al.
Publicado: (2010)

HAART and ATT in the HIV-positive patient with tuberculosis
por: Jhiens, Zi Z., et al.
Publicado: (2012)

Hypertension among HIV-Infected Adults Receiving Highly Active Antiretroviral Therapy (HAART) in Malaysia
por: Hejazi, Nazisa, et al.
Publicado: (2014)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPARγ-Dependent Pathways
por: Caron, Martine, et al.
Publicado: (2009)

Emergency of Primary NNRTI Resistance Mutations without Antiretroviral Selective Pressure in a HAART-Treated Child
por: Machado, Elizabeth S., et al.
Publicado: (2009)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
por: Alibhai, Arif, et al.
Publicado: (2010)

The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria
por: Taiwo, Olaniyi O, et al.
Publicado: (2010)

Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana
por: Lawler, Kathy, et al.
Publicado: (2011)

Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART)-naïve patients
por: Akinbami, Akinsegun, et al.
Publicado: (2012)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
por: Neeraja, M., et al.
Publicado: (2020)

Mitochondrial and Oxidative Impacts of Short and Long-term Administration of HAART on HIV Patients
por: Ikekpeazu, Joy E., et al.
Publicado: (2020)

Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART
por: Lopez, Carlos A., et al.
Publicado: (2010)

Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection
por: Gopalakrishnan, Vivek, et al.
Publicado: (2020)

Biochemical Manifestation of HIV Lipodystrophy Syndrome
por: Ihenetu, Kenneth, et al.
Publicado: (2012)

Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy and of HIV-1/ART-Associated Lipodystrophy Syndrome
por: Domingo, Pere, et al.
Publicado: (2010)

The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa
por: Tshamala, Honoré Kalombayi, et al.
Publicado: (2019)

Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction
por: de Waal, Reneé, et al.
Publicado: (2013)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Premature and accelerated aging: HIV or HAART?
por: Smith, Reuben L., et al.
Publicado: (2013)

A Case of Ocular Kaposi’s Sarcoma Successfully Treated with Highly Active Antiretroviral Therapy (HAART) Combined with Docetaxel
por: Jin, Chongfei, et al.
Publicado: (2018)

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)
por: Dold, Leona, et al.
Publicado: (2015)

Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria
por: Ekun, Oloruntoba Ayodele, et al.
Publicado: (2021)

Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
por: Tilahun, Anemut, et al.
Publicado: (2022)

Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load
por: Cornelissen, Marion, et al.
Publicado: (2006)

The Effect of Lipectomy/Liposuction on Lipid Profiles in Antiretroviral Drug-induced Lipodystrophy Syndrome
por: Doucas, Gabriel, et al.
Publicado: (2020)

Measurements of total and integrated HIV DNA demonstrate sporadic blips of unintegrated HIV DNA in HIV-positive patients on HAART
por: Mexas, A, et al.
Publicado: (2010)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study
por: Piloya, Thereza, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p3s6p43c1gb6755b2ks2o3sfhk